Using social media to help teenagers quit vaping
Social media support groups for adolescent vaping cessation
['FUNDING_R01'] · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · NIH-10952766
This study is testing a friendly program called 'Quit the Hit' on Instagram to help teens and young adults aged 13-21 quit vaping by connecting them with supportive chats and helpful tips from others who understand what they're going through.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO (nih funded) |
| Locations | 1 site (SAN FRANCISCO, UNITED STATES) |
| Trial ID | NIH-10952766 on ClinicalTrials.gov |
What this research studies
This research investigates a program called 'Quit the Hit' that utilizes Instagram direct message groups to support adolescents aged 13-21 in quitting vaping. The program was developed in collaboration with hundreds of adolescents and aims to provide a flexible and scalable intervention for vaping cessation. Participants will engage in supportive discussions and receive evidence-based strategies to help them stop using e-cigarettes. The effectiveness of this approach will be evaluated through a randomized controlled trial to assess abstinence rates.
Who could benefit from this research
Good fit: Ideal candidates for this research are adolescents aged 13-21 who are currently using e-cigarettes and are motivated to quit.
Not a fit: Patients who do not use e-cigarettes or are outside the age range of 13-21 may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide a novel and effective method for helping adolescents quit vaping, potentially reducing health risks associated with e-cigarette use.
How similar studies have performed: While there is limited research on social media-based vaping cessation programs, preliminary data from this program indicates promising results, suggesting a potential for success.
Where this research is happening
SAN FRANCISCO, UNITED STATES
- UNIVERSITY OF CALIFORNIA, SAN FRANCISCO — SAN FRANCISCO, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: LING, PAMELA MAY — UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
- Study coordinator: LING, PAMELA MAY
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.